India on US priority watch list: Concerns over IP rule mount
India is on the 'priority watch list' of the US in the latest Special 301 Report for 2026, released on April 30, due to persistent differences over intellectual property (IP) rules, especially in the pharmaceutical sector. India has remained on the priority watch list since the 1990s, reflecting long-standing divergences over patent standards and access to medicines. According to the…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
